ResMed (RMD) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $206.73 +2.80%
Revenue Growth %: +13.1%
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
PKE, LNN, More
Revenue Growth %: +13.1%
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.88, $0.10 better than the analyst estimate of $1.78. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.15 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Rivian raises 2026 delivery outlook after Q2 results top guidance
- Exclusive: Moomoo to launch unified ’Moomoo Engine’ trading toolkit
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
